Literature DB >> 21566120

The thyroid hormone receptors as modulators of skin proliferation and inflammation.

Constanza Contreras-Jurado1, Laura García-Serrano, Mariana Gómez-Ferrería, Clotilde Costa, Jesús M Paramio, Ana Aranda.   

Abstract

We have analyzed the role of the thyroid hormone receptors (TRs) in epidermal homeostasis. Reduced keratinocyte proliferation is found in interfollicular epidermis of mice lacking the thyroid hormone binding isoforms TRα1 and TRβ (KO mice). Similar results were obtained in hypothyroid animals, showing the important role of the liganded TRs in epidermal proliferation. In addition, KO and hypothyroid animals display decreased hyperplasia in response to 12-O-tetradecanolyphorbol-13-acetate. Both receptor isoforms play overlapping functional roles in the skin because mice lacking individually TRα1 or TRβ also present a proliferative defect but not as marked as that found in double KO mice. Defective proliferation in KO mice is associated with reduction of cyclin D1 expression and up-regulation of the cyclin-dependent kinase inhibitors p19 and p27. Paradoxically, ERK and AKT activity and expression of downstream targets, such as AP-1 components, are increased in KO mice. Increased p65/NF-κB and STAT3 phosphorylation and, as a consequence, augmented expression of chemokines and proinflammatory cytokines is also found in these animals. These results show that thyroid hormones and their receptors are important mediators of skin proliferation and demonstrate that TRs act as endogenous inhibitors of skin inflammation, most likely due to interference with AP-1, NF-κB, and STAT3 activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21566120      PMCID: PMC3129189          DOI: 10.1074/jbc.M111.218487

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  Thyroid hormone receptor β1 domains responsible for the antagonism with the ras oncogene: role of corepressors.

Authors:  S García-Silva; O Martínez-Iglesias; L Ruiz-Llorente; A Aranda
Journal:  Oncogene       Date:  2010-10-18       Impact factor: 9.867

2.  Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin.

Authors:  Andrzej Slominski; Jacobo Wortsman; Leonard Kohn; Kenneth B Ain; Gopalakrishnan M Venkataraman; Alexander Pisarchik; Jae Hoon Chung; Cesidio Giuliani; Mark Thornton; George Slugocki; Desmond J Tobin
Journal:  J Invest Dermatol       Date:  2002-12       Impact factor: 8.551

Review 3.  Involvement of NF-kappaB signalling in skin physiology and disease.

Authors:  Susanne Bell; Klaus Degitz; Martina Quirling; Nikolaus Jilg; Sharon Page; Korbinian Brand
Journal:  Cell Signal       Date:  2003-01       Impact factor: 4.315

4.  The expression of keratin k10 in the basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis.

Authors:  Mirentxu Santos; Jesus M Paramio; Ana Bravo; Angel Ramirez; José L Jorcano
Journal:  J Biol Chem       Date:  2002-03-11       Impact factor: 5.157

Review 5.  Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer.

Authors:  Sergei I Grivennikov; Michael Karin
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-16       Impact factor: 7.638

6.  Thyroid receptor agonists for the treatment of androgenetic alopecia.

Authors:  Jie Jack Li; Lorna H Mitchell; Robert L Dow
Journal:  Bioorg Med Chem Lett       Date:  2009-10-29       Impact factor: 2.823

7.  Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2.

Authors:  Xiao-Ding Peng; Pei-Zhang Xu; Mei-Ling Chen; Annett Hahn-Windgassen; Jennifer Skeen; Joel Jacobs; Deepa Sundararajan; William S Chen; Susan E Crawford; Kevin G Coleman; Nissim Hay
Journal:  Genes Dev       Date:  2003-06-01       Impact factor: 11.361

Review 8.  Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization.

Authors:  Giuseppe Viglietto; Maria Letizia Motti; Alfredo Fusco
Journal:  Cell Cycle       Date:  2002 Nov-Dec       Impact factor: 4.534

9.  c-Jun regulates eyelid closure and skin tumor development through EGFR signaling.

Authors:  Rainer Zenz; Harald Scheuch; Paul Martin; Carsten Frank; Robert Eferl; Lukas Kenner; Maria Sibilia; Erwin F Wagner
Journal:  Dev Cell       Date:  2003-06       Impact factor: 12.270

10.  Thyroid hormone antagonizes tumor necrosis factor-alpha signaling in pituitary cells through the induction of dual specificity phosphatase 1.

Authors:  Marina Lasa; Beatriz Gil-Araujo; Marta Palafox; Ana Aranda
Journal:  Mol Endocrinol       Date:  2009-12-23
View more
  18 in total

1.  Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.

Authors:  Brijesh K Singh; Rohit A Sinha; Jin Zhou; Madhulika Tripathi; Kenji Ohba; Mu-En Wang; Inna Astapova; Sujoy Ghosh; Anthony N Hollenberg; Karine Gauthier; Paul M Yen
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

2.  Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses.

Authors:  Elvira Alonso-Merino; Rosa Martín Orozco; Lidia Ruíz-Llorente; Olaia A Martínez-Iglesias; Juan Pedro Velasco-Martín; Ana Montero-Pedrazuela; Luisa Fanjul-Rodríguez; Constanza Contreras-Jurado; Javier Regadera; Ana Aranda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

3.  Topical L-thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?

Authors:  Ralf Paus; Yuval Ramot; Robert S Kirsner; Marjana Tomic-Canic
Journal:  Exp Dermatol       Date:  2020-08-28       Impact factor: 3.960

Review 4.  Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Cezary Skobowiat; Blazej Zbytek; Radomir M Slominski; Jeffery D Steketee
Journal:  Adv Anat Embryol Cell Biol       Date:  2012       Impact factor: 1.231

5.  Deciphering the regulatory logic of an ancient, ultraconserved nuclear receptor enhancer module.

Authors:  Pia D Bagamasbad; Ronald M Bonett; Laurent Sachs; Nicolas Buisine; Samhitha Raj; Joseph R Knoedler; Yasuhiro Kyono; Yijun Ruan; Xiaoan Ruan; Robert J Denver
Journal:  Mol Endocrinol       Date:  2015-04-13

Review 6.  Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesis.

Authors:  Stephen Hyter; Arup K Indra
Journal:  FEBS Lett       Date:  2013-02-05       Impact factor: 4.124

7.  Triiodothyronine (T3) inhibits hyaluronate synthesis in a human dermal equivalent by downregulation of HAS2.

Authors:  Tara Pouyani; Basma H Sadaka; Suzanne Papp; Lana Schaffer
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-02-09       Impact factor: 2.416

8.  Progranulin deficiency exaggerates, whereas progranulin-derived Atsttrin attenuates, severity of dermatitis in mice.

Authors:  Yun-Peng Zhao; Qing-Yun Tian; Chuan-Ju Liu
Journal:  FEBS Lett       Date:  2013-05-10       Impact factor: 4.124

Review 9.  Thyroid hormone action in epidermal development and homeostasis and its implications in the pathophysiology of the skin.

Authors:  G Mancino; C Miro; E Di Cicco; M Dentice
Journal:  J Endocrinol Invest       Date:  2021-03-08       Impact factor: 4.256

10.  Thyroid hormone and wound healing.

Authors:  Joshua D Safer
Journal:  J Thyroid Res       Date:  2013-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.